Boehringer Ingelheim

Partnering has been a central part of our company’s strategy for many years. We believe in working with others outside our company to build on our prescription medicine, consumer health, contract manufacturing and animal health businesses. In addition other partnering opportunities exist with our external research networking and venture fund teams.

Partnering is a key pillar of our prescription medicines business and forms an essential part of our drug discovery and development efforts. Find out more about how you can join our growing network of academic and industry partners in Working Together for Better Health. Improving the health and quality of life of humans and animals is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention.